Home › Lymfoom › New York › New York City
Lymfoom klinische studies in New York City, NY
33 studies voor Lymfoom zoeken deelnemers op locaties in en rond New York City (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
RekruterenFase 1
- Columbia University, New York
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
RekruterenFase 2
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RekruterenFase 1
- Memorial Sloan Kettering Cancer Center, New York
Epco, Zanu, Ritux for R/R FL or MZL
RekruterenFase 2
- Memorial Sloan Kettering Cancer Center, New York
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
RekruterenFase 2
- Memorial Sloan Kettering Cancer Center, New York
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
RekruterenFase 1
- Memorial Sloan Kettering Cancer Center, New York
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
RekruterenFase 1
- Cornell, New York
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
RekruterenFase 1/2
- Research Site, New York
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
RekruterenFase 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
RekruterenFase 1
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekruterenFase 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
RekruterenFase 2
- Memorial Sloan Kettering Cancer Center, New York
DALY II USA/ MB-CART2019.1 for DLBCL
RekruterenFase 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
RekruterenFase 1
- Memorial Sloan Kettering, New York
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
RekruterenFase 1/2
- Call for Information (Investigational Site 0031), New York
CD4CAR for CD4+ Leukemia and Lymphoma
RekruterenFase 1
- Albert Einstein Health Network, New York
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
RekruterenFase 1/2
- Dren Investigational Site 1, New York
- Dren Investigational Site 2, New York
A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)
RekruterenFase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RekruterenObservatieonderzoek
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
RekruterenFase 2
- Columbia University Irving Medical Center, New York
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RekruterenGezonde vrijwilligers welkom
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
RekruterenFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruterenFase 1/2
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of CAR-T Therapy in Older Patients
RekruterenObservatieonderzoek
- Memorial Sloan Kettering Cancer Center, New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekruterenFase 2
- Memorial Sloan Kettering, New York
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
RekruterenFase 2
- Icahn School of Medicine at Mount Sinai, New York
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
RekruterenFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
RekruterenObservatieonderzoek
- Memorial Sloan Kettering Cancer Center, New York
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
RekruterenFase 2
- Memorial Sloan Kettering Cancer Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Memorial Sloan Kettering Cancer Center, New York
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Rekruteren
- Columbia University, New York
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
RekruterenFase 1
- Columbia University Irving Medical Center, New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Rekruteren
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Lymfoom studies in andere steden
- Houston, TX34 studies
- Boston, MA33 studies
- Washington, DC23 studies
- Baldwin Park, CA21 studies
- Chicago, IL20 studies
- Durham, NC17 studies
- St. Louis, MO15 studies
- Philadelphia, PA15 studies
- Cleveland, OH14 studies
- Edison, NJ12 studies
- Atlanta, GA12 studies
- Seattle, WA12 studies
Andere studies in New York City
- Borstkanker136 studies
- Niet-kleincellige longkanker121 studies
- Kanker (alle vormen)109 studies
- Prostaatkanker103 studies
- Metastatische kanker93 studies
- Colorectale kanker78 studies
- Eierstokkanker69 studies
- Longkanker60 studies
- Multipel myeloom60 studies
- Aldermeesklierkanker60 studies
- Endometriumkanker52 studies
- Acute myeloïde leukemie51 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.